These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 3161676)
1. Deoxycytidine therapy in two patients with adenosine deaminase deficiency and severe immunodeficiency disease. Cowan MJ; Wara DW; Ammann AJ Clin Immunol Immunopathol; 1985 Oct; 37(1):30-6. PubMed ID: 3161676 [TBL] [Abstract][Full Text] [Related]
2. Intravenous deoxycytidine therapy in a patient with adenosine deaminase deficiency. Cowan MJ; Martin DW; Wara DW; Ammann AJ Adv Exp Med Biol; 1984; 165 Pt A():39-45. PubMed ID: 6609530 [No Abstract] [Full Text] [Related]
3. Effect of red cell transfusions, thymic hormone and deoxycytidine in severe combined immunodeficiency due to adenosine deaminase deficiency. Davies EG; Levinsky RJ; Webster DR; Simmonds HA; Perrett D Clin Exp Immunol; 1982 Nov; 50(2):303-10. PubMed ID: 6983936 [TBL] [Abstract][Full Text] [Related]
4. Rejection of bone marrow transplant and resistance of alloantigen reactive cells to in vivo deoxyadenosine in adenosine deaminase deficiency. Cowan MJ; Shannon KM; Wara DW; Ammann AJ Clin Immunol Immunopathol; 1988 Nov; 49(2):242-50. PubMed ID: 2971490 [TBL] [Abstract][Full Text] [Related]
5. Dipyridamole and intravenous deoxycytidine therapy in a patient with adenosine deaminase deficiency. Ammann AJ; Cowan MJ; Martin DW; Wara DW Birth Defects Orig Artic Ser; 1983; 19(3):117-20. PubMed ID: 6652234 [No Abstract] [Full Text] [Related]
6. Enzyme replacement and other biochemical approaches to the therapy of adenosine deaminase deficiency. Polmar SH Ciba Found Symp; 1978; (68):213-30. PubMed ID: 227649 [TBL] [Abstract][Full Text] [Related]
7. Biochemical and functional abnormalities in lymphocytes from an adenosine deaminase-deficient patient during enzyme replacement therapy. Hutton JJ; Wiginton DA; Coleman MS; Fuller SA; Limouze S; Lampkin BC J Clin Invest; 1981 Aug; 68(2):413-21. PubMed ID: 7263861 [TBL] [Abstract][Full Text] [Related]
8. Deoxyadenosine triphosphate as a potentially toxic metabolite in adenosine deaminase deficiency. Cohen A; Hirschhorn R; Horowitz SD; Rubinstein A; Polmar SH; Hong R; Martin DW Proc Natl Acad Sci U S A; 1978 Jan; 75(1):472-6. PubMed ID: 272665 [TBL] [Abstract][Full Text] [Related]
9. Adenosine deaminase deficiency without immunodeficiency: clinical and metabolic studies. Borkowsky W; Gershon AA; Shenkman L; Hirschhorn R Pediatr Res; 1980 Jul; 14(7):885-9. PubMed ID: 6251420 [TBL] [Abstract][Full Text] [Related]
10. Effect of adenosine deaminase replacement therapy on a child of adenosine deaminase deficiency with severe combined immunodeficiency disease. Tsuchiya S; Arai N; Kudo M; Konno T; Tada K; Yokoyama S Tohoku J Exp Med; 1979 Jul; 128(3):251-8. PubMed ID: 494247 [TBL] [Abstract][Full Text] [Related]
11. Limited effect of erythrocyte and plasma infusions in adenosine deaminase deficiency. Schmalstieg FC; Mills GC; Nelson JA; May LT; Goldman AS; Goldblum RM J Pediatr; 1978 Oct; 93(4):597-603. PubMed ID: 308999 [TBL] [Abstract][Full Text] [Related]
19. Immunoreactive adenosine deaminase (ADA) in cultured fibroblasts from patients with combined immunodeficiency disease. Carson DA; Goldblum R; Keightley R; Seegmiller JE Adv Exp Med Biol; 1977; 76A():463-70. PubMed ID: 855722 [No Abstract] [Full Text] [Related]
20. MLC vs CML in a case of T-cell immunodeficiency and ADA deficiency. Cohen F Birth Defects Orig Artic Ser; 1975; 11(1):486-8. PubMed ID: 125120 [No Abstract] [Full Text] [Related] [Next] [New Search]